忍者ブログ

リリースコンテナ第3倉庫



Home > ブログ > > [PR] Home > ブログ > 未選択 > 2012年 8月 08日, 午前 06:02 東部夏時間(米国・カナダ) Research and Markets: Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

[PR]

×

[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。

2012年 8月 08日, 午前 06:02 東部夏時間(米国・カナダ) Research and Markets: Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications

Research and Markets (http://www.researchandmarkets.com/research/h8nc6p/pharmaceutical_bio) has announced the addition of John Wiley and Sons Ltd's new book "Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications" to their offering.

“Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications”

This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations.

With a foreword by Robert Langer, Kenneth J Germeshausen Professor of Chemical and Biomedical Engineering at MIT and member of the National Academy of Engineering and the National Academy of Sciences.

Key Topics Covered:

Part One Concepts and Methods for Recombinant Drug Production

1 Pharmaceutical Biotechnology and Industrial Applications - Learning Lessons from Molecular Biology

2 Prokaryotic Cells in Biotech Production

3 Mammalian Cells in Biotech Production

4 Biopharmaceuticals from Plants

5 Production of Biopharmaceuticals in Transgenic Animals

6 Translation of New Technologies in Biomedicines: Shaping the Road from Basic Research to Drug Development and Clinical Application - and Back Again

Part Two Bringing the Drug into Action - From Downstreaming to Approval

7 Overview and Classification of Approved Recombinant Drugs

8 Downstream Processing

9 Characterization of Recombinant Proteins

10 Formulation Strategies for Recombinant Protein and Related Biotech Drugs

11 Drug Approval in the European Union and United States

12 Patents in the Pharmaceutical Biotechnology Industry: Legal and Ethical Issues

13 Biosimilar Drugs

14 Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins

Part Three Vaccines

15 Scientific, Technical, and Economic Aspects of Vaccine Research and Development

16 New Nanobiotechnological Strategies for the Development of Vectors for Cancer Vaccines

17 Recombinant Vaccines: Development, Production, and Application

Part Four Recent Applications in Pharmaceutical Biotechnology

18 In Silico and Ultrahigh-Throughput Screenings (uHTS) in Drug Discovery: an Overview

19 Metabolic Engineering of Medicinal Plants and Microorganisms for the Production of Natural Products

20 Metabolomics as a Bioanalytical Tool for Characterization of Medicinal Plants and Their Phytomedical Preparations

21 Integration of Biotechnologies for the Development of Personalized Medicine

22 Xenotransplantation in Pharmaceutical Biotechnology

23 Nutraceuticals-Functional Foods for Improving Health and Preventing Disease

Authors

Oliver Kayser.

Heribert Warzecha.

For more information visit http://www.researchandmarkets.com/research/h8nc6p/pharmaceutical_bio

Source: John Wiley and Sons Ltd

連絡先

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

PR

Comment0 Comment

Comment Form

  • お名前name
  • タイトルtitle
  • メールアドレスmail address
  • URLurl
  • コメントcomment
  • パスワードpassword